MUC2 and cancer: In regards to cell lines, to date, there are several transformed colonic cell lines that can produce gel-forming mucins including Methotrexate-adapted HT-29 cells (76, 77), and LS174T cells (78), the latter which can produce complex glycosylated MUC2 to explore host-pathogen interactions and glycomic changes in cancer (79).